Cas:9024-06-0 Bacillus stearothermophilus Alanine Racemase manufacturer & supplier

Chemical Name:Bacillus stearothermophilus Alanine Racemase

CAS.NO:9024-06-0

Synonyms:1-(3-C-Ethynylpentofuranosyl)-2,4(1H,3H)-pyrimidinedione;2,4(1H,3H)-Pyrimidinedione, 1-(3-C-ethynylpentofuranosyl)-

Molecular Formula:C₁₁H₁₂N₂O₆

Molecular Weight:268.223

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.7±0.1 g/cm3

Index of Refraction:1.680

PSA:

Exact Mass:268.069550

LogP:0.02

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1-(3-C-Ethynylpentofuranosyl)-2,4(1H,3H)-pyrimidinedione chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,4(1H,3H)-Pyrimidinedione, 1-(3-C-ethynylpentofuranosyl)- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-(3-C-Ethynylpentofuranosyl)-2,4(1H,3H)-pyrimidinedione Use and application,1-(3-C-Ethynylpentofuranosyl)-2,4(1H,3H)-pyrimidinedione technical grade,usp/ep/jp grade.

Related News: The company��s proprietary induced pluripotent stem cell (iPSC) product platform enables mass production of off-the-shelf, engineered, homogeneous cell products that can be administered with multiple doses to deliver more effective pharmacologic activity, including in combination with cycles of other cancer treatments. Bacillus stearothermophilus Alanine Racemase manufacturer Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates. Bacillus stearothermophilus Alanine Racemase supplier Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates. Bacillus stearothermophilus Alanine Racemase vendor The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy. Bacillus stearothermophilus Alanine Racemase factory Coupled with the poor global pesticide industry situation this year, the weakening of downstream customer demand has affected the sales of pesticide intermediates.